Latest Close
$1.44
News
FBLG
FibroBiologics, Inc. News
This news view pulls recent coverage and headlines tied to FBLG.
1y Change
-$10.34 (-87.78%)
Market Cap
$9,587,798.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
none
FibroBiologics Announces Australian Patent Accepted for Cannabidiol Adjuvant Therapy for the Treatment of Degenerative Disc Disease
PR Newswire • Aug 20, 2026
Read articleFibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints
PR Newswire • Aug 18, 2026
Read articleFibroBiologics Granted U.S. Patent Covering the Use of Fibroblasts to Enhance Survival and Function of Transplanted Insulin-Producing Islets
PR Newswire • Aug 11, 2026
Read articleFibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage
PR Newswire • Aug 5, 2026
Read articleFibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate
PR Newswire • Jul 31, 2026
Read articleFibroBiologics Appoints Kathleen "Kate" Rubins, Ph.D. to Board of Directors
PR Newswire • Jul 9, 2026
Read article